Cited by 6,873HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Prevention of HIV-1 infection with early antiretroviral therapy.

Open access

Cohen, Myron S., Chen, Ying Q., McCauley, Marybeth, Gamble, Theresa, Hosseinipour, Mina C., Kumarasamy, Nagalingeswaran, Hakim, James G., Kumwenda, Johnstone, Grinsztejn, Beatriz, Pilotto, Jose H.S., Godbole, Sheela V., Mehendale, Sanjay, Chariyalertsak, Suwat, Santos, Breno R., Mayer, Kenneth H., Hoffman, Irving F., Eshleman, Susan H., Piwowar-Manning, Estelle, Wang, Lei, Makhema, Joseph, Mills, Lisa A., de Bruyn, Guy, Sanne, Ian, Eron, Joseph, Gallant, Joel, Havlir, Diane, Swindells, Susan, Ribaudo, Heather, Elharrar, Vanessa, Burns, David, Taha, Taha E., Nielsen-Saines, Karin, Celentano, David, Essex, Max, Fleming, Thomas R.·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1105243PMC PMC3200068

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic millimeter were randomly assigned in a 1:1 ratio to receive antiretroviral therapy either immediately (early therapy) or after a decline in the CD4 count or the onset of HIV-1-related symptoms (delayed therapy). The primary prevention end point was linked HIV-1 transmission in HIV-1-negative partners. The primary clinical end point was the earliest occurrence of pulmonary tuberculosis, severe bacterial infection, a World Health Organization stage 4 event, or death. RESULTS: As of February 21, 2011, a total of 39 HIV-1 transmissions were observed (incidence rate, 1.2 per 100 person-years; 95% confidence interval [CI], 0.9 to 1.7); of these, 28 were virologically linked to the infected partner (incidence rate, 0.9 per 100 person-years, 95% CI, 0.6 to 1.3). Of the 28 linked transmissions, only 1 occurred in the early-therapy group (hazard ratio, 0.04; 95% CI, 0.01 to 0.27; P<0.001). Subjects receiving early therapy had fewer treatment end points (hazard ratio, 0.59; 95% CI, 0.40 to 0.88; P=0.01). CONCLUSIONS: The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 052 ClinicalTrials.gov number, NCT00074581.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1105243

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Self-citation
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N. K., Serwadda, D., Li, C., Wabwire‐Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 2,990
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Granich, R., Gilks, C. F., Dye, C., Cock, K. M. D., & Williams, B. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,987
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
Braitstein, P. K. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68337-2 · Cited by 1,106
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citation
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
Donnell, D. J., Baeten, J. M., Kiarie, J. N., Thomas, K. K., Stevens, W. S., Cohen, C. R., McIntyre, J. A., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 970
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780
Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco
Das, M., Chu, P. L., Santos, G., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
Sterne, J. A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60612-7 · Cited by 748

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

Smith K, 2011, Curr Opin HIV AIDS, 6, 315

Sorted by citations

Items 601–700 of 1,024

Dolutegravir for the treatment of HIV
Katlama, C., & Murphy, R. L. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.661713 · Cited by 77
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Fogel, J. M., Wang, L., Parsons, T. L., Ou, S., Piwowar‐Manning, E., Chen, Y. Q., Mudhune, V., Hosseinipour, M. C., Kumwenda, J., Hakim, J. G., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit390 · Cited by 77
Self-citation
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy
Mujugira, A., Celum, C., Coombs, R. W., Campbell, J. D., Ndase, P., Ronald, A., Were, E. O., Bukusi, E. A., Mugo, N., Kiarie, J. N., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001019 · Cited by 77
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Anglemyer, A. T., Rutherford, G. W., Baggaley, R. C., Egger, M., & Siegfried, N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009153.pub2 · Cited by 84
Impact of cocaine abuse on HIV pathogenesis
Dash, S., Balasubramaniam, M., Villalta, F., Dash, C., & Pandhare, J. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01111 · Cited by 67
From caution to urgency: the evolution of HIV testing and counselling in Africa
Baggaley, R. C., Hensen, B., Ajose, O., Grabbe, K., Wong, V. J., Schilsky, A., Lo, Y.-R., Lule, F., Granich, R., & Hargreaves, J. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.100818 · Cited by 75
Adherence to Antiretroviral Therapy and Clinical Outcomes Among Young Adults Reporting High-Risk Sexual Behavior, Including Men Who Have Sex with Men, in Coastal Kenya
Graham, S. M., Mugo, P. M., Gichuru, E., Thiong’o, A. N., Macharia, M., Okuku, H. S., van der Elst, E., Price, M. A., Muraguri, N., & Sanders, E. J. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0445-9 · Cited by 76
HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes
Delva, W., Eaton, J. W., Meng, F., Fraser, C., White, R. G., Vickerman, P. T., Boily, M., & Hallett, T. B. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001258 · Cited by 76
Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1–Infected Men Who Have Sex With Men
Gianella, S., Smith, D. M., Vargas, M. V., Little, S. J., Richman, D. D., Daar, E. S., Dubé, M. P., Zhang, F., Ginocchio, C. C., Haubrich, R., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit252 · Cited by 76
Novel host restriction factors implicated in HIV-1 replication
Ghimire, D., Rai, M., & Gaur, R. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001026 · Cited by 83
Antiretroviral Therapy for Prevention of HIV Transmission in HIV-Discordant Couples
Anglemyer, A. T., Horváth, H., & Rutherford, G. W. (2013) · JAMA · doi:10.1001/jama.2013.278328 · Cited by 76
Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
Alistar, S. S., Grant, P., & Bendavid, E. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-46 · Cited by 80
The HIV care continuum in Latin America: challenges and opportunities
Piñeirúa, A., Sierra-Madero, J. G., Cahn, P. E., Palmero, R. N. G., Martínez, E., Young, B., & del Rı́o, C. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00108-5 · Cited by 76
High levels of retention in care with streamlined care and universal test and treat in East Africa
Brown, L. B., Havlir, D. V., Ayieko, J., Mwangwa, F., Owaraganise, A., Kwarisiima, D., Jain, V., Ruel, T., Clark, T. D., Chamie, G., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001250 · Cited by 76
Self-citation
Implementation of an innovative, integrated electronic medical record (EMR) and public health information exchange for HIV/AIDS
Herwehe, J., Wilbright, W., Abrams, A., Bergson, S., Foxhood, J., Kaiser, M., Smith, L., Xiao, K., Zapata, A., & Magnus, M. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000412 · Cited by 92
Early initiation of antiretroviral therapy in HIV-infected adults and adolescents
Anglemyer, A. T., Rutherford, G. W., Easterbrook, P., Horváth, H., Vitória, M., Jan, M., & Doherty, M. C. (2014) · AIDS · doi:10.1097/qad.0000000000000232 · Cited by 75
The HIV care cascade in Switzerland
Kohler, P. P., Schmidt, A. J., Cavassini, M. L., Furrer, H., Calmy, A., Battegay, M., Bernasconi, E., Ledergerber, B., & Vernazza, P. (2015) · AIDS · doi:10.1097/qad.0000000000000878 · Cited by 75
Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe
Mwenge, L., Sande, L. A., Mangenah, C., Ahmed, N., Kanema, S., d’Elbée, M., Sibanda, E. L., Kalua, T., Ncube, G., Johnson, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185740 · Cited by 76
Cost‐effectiveness of pre‐exposure prophylaxis targeted to high‐risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda
Ying, R., Sharma, M., Heffron, R. A., Celum, C., Baeten, J. M., Katabira, E. T., Bulya, N., & Barnabas, R. V. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.4.20013 · Cited by 79
Optimizing Content for Pre-exposure Prophylaxis (PrEP) Counseling for Men Who Have Sex with Men: Perspectives of PrEP Users and High-Risk PrEP Naïve Men
Taylor, S. W., Mayer, K. H., Elsesser, S. A., Mimiaga, M. J., O’Cleirigh, C. M., & Safren, S. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0617-7 · Cited by 80
Self-citation
Disclosure, Knowledge of Partner Status, and Condom Use Among HIV-Positive Patients Attending Clinical Care in Tanzania, Kenya, and Namibia
Bachanas, P. J., Medley, A. M., Pals, S. L., Kidder, D. P., Antelman, G., Benech, I., DeLuca, N., Nuwagaba‐Biribonwoha, H., Muhenje, O., Cherutich, P., et al. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0388 · Cited by 75
Syndemic Vulnerability, Sexual and Injection Risk Behaviors, and HIV Continuum of Care Outcomes in HIV-Positive Injection Drug Users
Mizuno, Y., Purcell, D. W., Knowlton, A. R., Wilkinson, J. D., Gourevitch, M. N., & Knight, K. R. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0890-0 · Cited by 76
Moderate Levels of Depression Predict Sexual Transmission Risk in HIV-Infected MSM: A Longitudinal Analysis of Data From Six Sites Involved in a “Prevention for Positives” Study
O’Cleirigh, C. M., Newcomb, M. E., Mayer, K. H., Skeer, M. R., Traeger, L. N., & Safren, S. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0462-8 · Cited by 77
Self-citation
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
Eshleman, S. H., Hudelson, S. E., Redd, A. D., Swanstrom, R. I., Ou, S., Zhang, X. C., Ping, L., Piwowar‐Manning, E., Porcella, S. F., Sievers, M. F., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001158 · Cited by 74
Self-citation
Disparities in HIV transmission risk among HIV-infected black and white men who have sex with men, United States, 2009
Beer, L., Oster, A. M., Mattson, C. L., & Skarbinski, J. (2013) · AIDS · doi:10.1097/qad.0000000000000021 · Cited by 74
Rates and Correlates of Antiretroviral Therapy Use and Virologic Suppression Among Perinatally and Behaviorally HIV-Infected Youth Linked to Care in the United States
Kahana, S. Y., Fernandez, M. I., Wilson, P. A., Bauermeister, J. A., Lee, S., Wilson, C. M., & Hightow‐Weidman, L. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000408 · Cited by 75
Serious Non-AIDS events: Immunopathogenesis and interventional strategies
Hsu, D. C., Sereti, I., & Ananworanich, J. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-29 · Cited by 73
2014 European Guideline on HIV testing
Gökengin, D., Geretti, A. M., Begovać, J., Palfreeman, A., Stevanovic, M., Тарасенко, О. М., & Radcliffe, K. W. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414531244 · Cited by 74
Linking and Retaining HIV Patients in Care: The Importance of Provider Attitudes and Behaviors
Magnus, M., Herwehe, J., Murtaza-Rossini, M., Reine, P. M., Cuffie, D., Gruber, D., & Kaiser, M. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0423 · Cited by 74
Interaction Between Lactobacilli, Bacterial Vaginosis-Associated Bacteria, and HIV Type 1 RNA and DNA Genital Shedding in U.S. and Kenyan Women
Mitchell, C. M., Balkus, J. E., Fredricks, D. N., Liu, C., McKernan, J. L., Frenkel, L. M., Mwachari, C., Luque, A. E., Cohn, S. E., Cohen, C. R., et al. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0187 · Cited by 74
Beyond the Bisexual Bridge
Jeffries, W. L. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.05.002 · Cited by 74
Improved Virologic Suppression With HIV Subspecialty Care in a Large Prison System Using Telemedicine: An Observational Study With Historical Controls
Young, J. D., Patel, M. C., Badowski, M., Mackesy‐Amiti, M. E., Vaughn, P., Shicker, L., Puisis, M., & Ouellet, L. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu222 · Cited by 74
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
BRENNER, B. G., & Wainberg, M. A. (2016) · Virus Research · doi:10.1016/j.virusres.2016.07.006 · Cited by 76
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Okwundu, C. I., Uthman, O. A., & Okoromah, C. A. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007189.pub3 · Cited by 80
HIV/AIDS-Related Stigmatizing and Discriminatory Attitudes and Recent HIV Testing Among Men Who Have Sex With Men in Beijing
Li, X., Lu, H., Ma, X., Sun, Y., He, X., Li, C., Raymond, H. F., McFarland, W., Pan, S. W., Shao, Y., et al. (2012) · AIDS and Behavior · doi:10.1007/s10461-012-0161-x · Cited by 74
Improved HIV-related outcomes associated with implementation of a novel public health information exchange
Magnus, M., Herwehe, J., Gruber, D., Wilbright, W., Shepard, E., Abrams, A., Foxhood, J., Smith, L., Xiao, K., DeYoung, K., et al. (2012) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2012.06.005 · Cited by 73
“Hurdles on the path to 90-90-90 and beyond”: Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat
Ayieko, J., Brown, L. B., Anthierens, S., Rie, A. V., Getahun, M., Charlebois, E. D., Petersen, M. L., Clark, T. D., Kamya, M. R., Cohen, C. R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202990 · Cited by 73
Self-citation
Viral Suppression and Antiretroviral Medication Adherence Among Alcohol Using HIV-Positive Adults
Kalichman, S. C., Grebler, T., Amaral, C. M., McNerney, M., White, D., Kalichman, M. O., Cherry, C., & Eaton, L. A. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9353-7 · Cited by 73
Resurgence of HIV Infection among Men Who Have Sex with Men in Switzerland: Mathematical Modelling Study
van Sighem, A., Vidondo, B., Glass, T. R., Bucher, H. C., Vernazza, P., Gebhardt, M. D., de Wolf, F., Derendinger, S., Jeannin, A., Bezemer, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044819 · Cited by 73
Geography Should Not Be Destiny: Focusing HIV/AIDS Implementation Research and Programs on Microepidemics in US Neighborhoods
Nunn, A. S., Yolken, A., Cutler, B. H., Trooskin, S. B., Wilson, P., Little, S. J., & Mayer, K. H. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301864 · Cited by 75
Self-citation
All Black People Are Not Alike: Differences in HIV Testing Patterns, Knowledge, and Experience of Stigma Between U.S.-Born and Non–U.S.-Born Blacks in Massachusetts
Ojikutu, B. O., Nnaji, C., Sithole-Berk, J., Schneider, K. L., Higgins-Biddle, M., Cranston, K., & Earls, F. J. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0312 · Cited by 73
Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol
Gwadz, M. V., Collins, L. M., Cleland, C. M., Leonard, N. R., Wilton, L., Gandhi, M., Braithwaite, R. S., Perlman, D. C., Kutnick, A. H., & Ritchie, A. S. (2017) · BMC Public Health · doi:10.1186/s12889-017-4279-7 · Cited by 76
The next generation of the World Health Organization's global antiretroviral guidance
Hirnschall, G. O., Harries, A. D., Easterbrook, P., Doherty, M. C., & Ball, A. L. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.1.18757 · Cited by 72
HIV Testing and Counseling Leads to Immediate Consistent Condom Use Among South African Stable HIV-Discordant Couples
Rosenberg, N. E., Pettifor, A. E., de Bruyn, G., Westreich, D. J., Delany‐Moretlwe, S., Behets, F., Maman, S., Coetzee, D. J., Kamupira, M., & Miller, W. C. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31827971ca · Cited by 73
HIV Treatment as Prevention: Models, Data, and Questions—Towards Evidence-Based Decision-Making
The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001259 · Cited by 76
Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster‐randomized trial in rural South Africa
Plazy, M., Farouki, K. E., Iwuji, C. C., Okesola, N., Orne‐Gliemann, J., Larmarange, J., Lert, F., Newell, M., Dabis, F., Dray‐Spira, R., et al. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20913 · Cited by 72
Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004–2014
Chen, Y., Snowden, J. M., McFarland, W., & Raymond, H. F. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1357-2 · Cited by 77
Self-citation
Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa
Bor, J. H., Fox, M. P., Rosen, S. B., Venkataramani, A. S., Tanser, F. C., Pillay, D., & Bärnighausen, T. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002463 · Cited by 72
Cohort Profile: Seek and Treat for the Optimal Prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC)
Heath, K., Samji, H., Nosyk, B., Colley, G., Gilbert, M., Hogg, R. S., & Montaner, J. S. G. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu070 · Cited by 72
A National Behavioral and Clinical Surveillance System of Adults With Diagnosed HIV (The Medical Monitoring Project): Protocol for an Annual Cross-Sectional Interview and Medical Record Abstraction Survey
Beer, L., Johnson, C. H., Fagan, J. L., Frazier, E. L., Nyaku, M. A., Craw, J. A., Sanders, C., Luna‐Gierke, R. E., & Shouse, R. L. (2019) · JMIR Research Protocols · doi:10.2196/15453 · Cited by 72
Measuring What Matters: Development of Standard HIV Core Indicators across the U.S. Department of Health and Human Services
Valdiserri, R. O., Forsyth, A. D., Yakovchenko, V., & Koh, H. K. (2013) · Public Health Reports · doi:10.1177/003335491312800504 · Cited by 72
Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.
Masese, L., Baeten, J. M., Richardson, B. A., Bukusi, E., John-Stewart, G., Graham, S. M., Shafi, J., Kiarie, J., Overbaugh, J., & McClelland, R. S. (2015) · AIDS · doi:10.1097/qad.0000000000000646 · Cited by 70
Depression Prevalence, Antidepressant Treatment Status, and Association with Sustained HIV Viral Suppression Among Adults Living with HIV in Care in the United States, 2009–2014
Gokhale, R. H., Weiser, J. K., Sullivan, P. S., Luo, Q., Shu, F., & Bradley, H. M. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02613-6 · Cited by 71
Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States
Chemaitelly, H. S., Nagelkerke, N. J. D., Omori, R., & Abu-Raddad, L. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214151 · Cited by 71
Combating HIV stigma in low‐ and middle‐income healthcare settings: a scoping review
Smith, M. K., Xu, R., Hunt, S., Wei, C., Tucker, J. D., Tang, W., Luo, D., Xue, H., Wang, C., Yang, L., et al. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25553 · Cited by 71
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa
van de Vijver, D. A. M. C., Nichols, B. E., Abbas, U. L., Boucher, C. A., Cambiano, V., Eaton, J. W., Glaubius, R. L., Lythgoe, K., Mellors, J. W., Phillips, A. N., et al. (2013) · AIDS · doi:10.1097/01.aids.0000433237.63560.20 · Cited by 73
Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000–2011
Peterman, T. A., Newman, D. R., Maddox, L. M., Schmitt, K., & Shiver, S. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414531243 · Cited by 76
Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection
Hamlyn, E., Ewings, F. M., Porter, K., Cooper, D. A., Tambussi, G., Schechter, M., Pedersen, C., Okulicz, J. F., McClure, M., Babiker, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043754 · Cited by 71
Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda
Barnabas, R. V., van Rooyen, H., Tumwesigye, E., Brantley, J., Baeten, J. M., van Heerden, A. C., Turyamureeba, B., Joseph, P., Krows, M. L., Thomas, K. K., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)00020-5 · Cited by 72
Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial
McNairy, M. L., Lamb, M. R., Gachuhi, A. B., Nuwagaba‐Biribonwoha, H., Burke, S. A., Mazibuko, S., Okello, V., Ehrenkranz, P. D., Sahabo, R., & El‐Sadr, W. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002420 · Cited by 73
Recent Advances (2011-2012) in Technology-Delivered Interventions for People Living with HIV
Pellowski, J. A., & Kalichman, S. C. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0133-9 · Cited by 66
Pre-exposure prophylaxis for HIV prevention: how to predict success
Kashuba, A. D. M., Patterson, K. B., Dumond, J. B., & Cohen, M. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61852-7 · Cited by 72
Self-citation
HIV testing approaches to reach the first UNAIDS 95% target in sub-Saharan Africa
Chamie, G., Napierala, S., Agot, K. E., & Thirumurthy, H. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00023-0 · Cited by 68
A conceptual framework for understanding HIV risk behavior in the context of supporting fertility goals among HIV-serodiscordant couples
Crankshaw, T. L., Matthews, L. T., Giddy, J., Kaida, A., Ware, N. C., Smit, J. A., & Bangsberg, D. R. (2012) · Reproductive Health Matters · doi:10.1016/s0968-8080(12)39639-0 · Cited by 74
Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review
Pottie, K. C., Medu, O., Welch, V. A., Dahal, G. P., TYNDALL, M. W., Rader, T., & Wells, G. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006859 · Cited by 70
Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA
Deblonde, J., Sasse, A., del Amo, J., Burns, F. M., Delpech, V., Cowan, S. A., LeVoy, M., Keith, L., Pharris, A., Amato‐Gauci, A. J., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-2571-y · Cited by 71
A Livelihood Intervention to Reduce the Stigma of HIV in Rural Kenya: Longitudinal Qualitative Study
Tsai, A. C., Hatcher, A. M., Bukusi, E. A., Weke, E., Hufstedler, L. L., Dworkin, S. L., Kodish, S. R., Cohen, C. R., & Weiser, S. D. (2016) · AIDS and Behavior · doi:10.1007/s10461-015-1285-6 · Cited by 70
Prevention of HIV-1 infection with early antiretroviral therapy
Rayment, M. (2012) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2012-100379 · Cited by 72
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
Henderson, G., Peay, H., Kroon, E., Cadigan, R., Meagher, K., Jupimai, T., Gilbertson, A., Fisher, J., Ormsby, N., Chomchey, N., et al. (2017) · Journal of Medical Ethics · doi:10.1136/medethics-2017-104433 · Cited by 73
Treatment Is More Than Prevention: Perceived Personal and Social Benefits of Undetectable = Untransmittable Messaging Among Sexual Minority Men Living with HIV
Rendina, H. J., Talan, A. J., Cienfuegos-Szalay, J., Carter, J. A., & Shalhav, O. (2020) · AIDS Patient Care and STDs · doi:10.1089/apc.2020.0137 · Cited by 71
Linkage to care following a home‐based HIV counselling and testing intervention in rural South Africa
Naik, R., Doherty, T., Jackson, D. J., Tabana, H., Swanevelder, S. A., Thea, D. M., Feeley, F. G., & Fox, M. P. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.1.19843 · Cited by 69
Guidelines for antiretroviral therapy in adults
Meintjes, G., & Maartens, G. (2012) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v13i3.125 · Cited by 69
Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study
Smith, J., Anderson, S., Harris, K. L., McGillen, J. B., Lee, E., Garnett, G. P., & Hallett, T. B. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30036-4 · Cited by 67
Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial
on behalf of the EPIC-NSW study group, Zablotska, I., Selvey, C., Guy, R., Price, K., Holden, J., Schmidt, H.-M. A., McNulty, A. M., Smith, D., Jin, F., et al. (2018) · BMC Public Health · doi:10.1186/s12889-017-5018-9 · Cited by 74
A Systematic Review and Meta-analysis of Antiretroviral Therapy (ART) Adherence Interventions for Women Living with HIV
Pellowski, J. A., Price, D. M., Harrison, A. D., Tuthill, E. L., Myer, L., Operario, D., & Lurie, M. N. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2341-9 · Cited by 69
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine
Vasylyev, M., Skrzat‐Klapaczyńska, A., Bernardino, J. I., Săndulescu, O., Gilles, C., Libois, A., Curran, A., Spinner, C. D., Rowley, D., Bickel, M., et al. (2022) · The Lancet HIV · doi:10.1016/s2352-3018(22)00125-4 · Cited by 69
Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts
Maskew, M., Sharpey-Schafer, K., Voux, L. D., Crompton, T., Bor, J. H., Rennick, M., Chirowodza, A., Miot, J., Molefi, S., Onaga, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16062-0 · Cited by 72
Self-citation
Advances in HIV Prevention for Serodiscordant Couples
Muessig, K. E., & Cohen, M. S. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0225-9 · Cited by 75
Self-citation
Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia
Angelis, K., Albert, J., Mamais, I., Magiorkinis, G., Hatzakis, A. E., Hamouda, O., Struck, D., Vercauteren, J., Wensing, A. M. J., Alexiev, I., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu666 · Cited by 70
Understanding Local Spatial Variation Along the Care Continuum
Goswami, N. D., Schmitz, M. M., Sanchez, T., Dasgupta, S., Sullivan, P. S., Cooper, H. L. F., Rane, D., Kelly, J., del Rio, C., & Waller, L. A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000914 · Cited by 69
Recent Insights into the HIV/AIDS Pandemic
Becerra, J. C., Bildstein, L. S., & Gach, J. S. (2016) · Microbial Cell · doi:10.15698/mic2016.09.529 · Cited by 70
Progression and Transmission of HIV/AIDS (PATH 2.0)
Gopalappa, C., Farnham, P. G., Chen, Y.-H., & Sansom, S. L. (2016) · Medical Decision Making · doi:10.1177/0272989x16668509 · Cited by 67
Self-citation
Uptake of HIV testing in Burkina Faso: an assessment of individual and community-level determinants
Kirakoya‐Samadoulougou, F., Jean, K., & Maheu‐Giroux, M. (2017) · BMC Public Health · doi:10.1186/s12889-017-4417-2 · Cited by 68
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
Baggaley, R. F., Irvine, M. A., Leber, W., Cambiano, V., Figueroa, J. N., McMullen, H., Anderson, J., Santos, A. C., Terris‐Prestholt, F., Miners, A. H., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30123-6 · Cited by 69
The Potential Impact of Expanding Antiretroviral Therapy and Combination Prevention in Vietnam
Kato, M., Granich, R., Bui, D. D., Tran, H. V., Nadol, P., Jacka, D., Sabin, K. M., Suthar, A. B., Mesquita, F., Lo, Y. R., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829b535b · Cited by 68
Suboptimal geographic accessibility to comprehensive HIV care in the US: regional and urban–rural differences
MASIANO, S. P., Martin, E. G., Bono, R. S., Dahman, B. A., Sabik, L. M., Belgrave, F. Z., Adimora, A. A., & Kimmel, A. D. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25286 · Cited by 68
The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
Zhang, Z., Zhou, Y., Yang, J., Hu, K., & Huang, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-5735-9 · Cited by 68
The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review
Kanazawa, J. T., Saberi, P., Sauceda, J. A., & Dubé, K. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0126 · Cited by 68
Alcohol Use and the Risk of Communicable Diseases
Morojele, N. K., Shenoi, S., Shuper, P. A., Braithwaite, R. S., & Rehm, J. T. (2021) · Nutrients · doi:10.3390/nu13103317 · Cited by 76
My intention was a child but I was very afraid : fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya
Ngure, K., Baeten, J. M., Mugo, N., Curran, K. G., Vusha, S., Heffron, R. A., Celum, C., & Shell‐Duncan, B. (2014) · AIDS Care · doi:10.1080/09540121.2014.911808 · Cited by 68
Community-Based Harm Reduction Substance Abuse Treatment with Methamphetamine-Using Men Who Have Sex with Men
Carrico, A. W., Flentje, A., Gruber, V. A., Woods, W. J., Discepola, M. V., Dilworth, S. E., Neilands, T. B., Jain, J. P., & Siever, M. D. (2014) · Journal of Urban Health · doi:10.1007/s11524-014-9870-y · Cited by 68
Voluntary Medical Male Circumcision
Reed, J. B., Njeuhmeli, E., Thomas, A. G., Bacon, M. C., Bailey, R., Cherutich, P., Curran, K., Dickson, K., Farley, T., Hankins, C. A., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825cac4e · Cited by 67
Abriendo Puertas: Baseline Findings from an Integrated Intervention to Promote Prevention, Treatment and Care among FSW Living with HIV in the Dominican Republic
Donastorg, Y., Barrington, C., Pérez, M., & Kerrigan, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088157 · Cited by 68
How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
Terris‐Prestholt, F., Hanson, K., MacPhail, C. L., Vickerman, P. T., Rees, H., & Watts, C. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083193 · Cited by 66
Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS)
Callander, D., Moreira, C., El‐Hayek, C., Asselin, J., van Gemert, C. E., Smith, L. W., Nguyen, L., Dimech, W. J., Boyle, D. I., Donovan, B. J., et al. (2018) · JMIR Research Protocols · doi:10.2196/11028 · Cited by 68
Stigma and racial/ethnic HIV disparities: Moving toward resilience.
Earnshaw, V. A., Bogart, L. M., Dovidio, J. F., & Williams, D. R. (2015) · Stigma and Health · doi:10.1037/2376-6972.1.s.60 · Cited by 68
Exploring Concentration Response in HIV Pre-Exposure Prophylaxis to Optimize Clinical Care and Trial Design
Hendrix, C. W. (2013) · Cell · doi:10.1016/j.cell.2013.09.030 · Cited by 71
The global north
Sullivan, P. S., Jones, J. S., & Baral, S. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000039 · Cited by 67
Behind the Cascade
Eberhart, M. G., Yehia, B. R., Hillier, A. E., Voytek, C. D., Blank, M. B., Frank, I., Metzger, D. S., & Brady, K. A. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a90112 · Cited by 67
Peru's HIV care continuum among men who have sex with men and transgender women: opportunities to optimize treatment and prevention
Chow, J. Y., Konda, K. A., Bórquez, A., Caballero, P., Silva‐Santisteban, A., Klausner, J. D., & Cáceres, C. F. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416645727 · Cited by 67

Authors: Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L. A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S., Ribaudo, H., Elharrar, V., Burns, D., Taha, T. E., Nielsen-Saines, K., Celentano, D., Essex, M., & Fleming, T. R.
Affiliations: University of North Carolina at Chapel Hill (US)
Fred Hutch Cancer Center (US)
YR Gaitonde Centre for AIDS Research and Education (IN)
University of Zimbabwe (ZW)
Johns Hopkins University (US)
National AIDS Research Institute (IN)
Chiang Mai University (TH)
Fenway Health (US)
Harvard University (US)
Kenya Medical Research Institute (KE)
University of California, San Francisco (US)
University of Nebraska Medical Center (US)
National Institutes of Health (US)
University of Washington (US)
ORCID: Cohen, Myron S.
Chen, Ying Q.
Gamble, Theresa
Hosseinipour, Mina C.
Kumarasamy, Nagalingeswaran
Hakim, James G.
Kumwenda, Johnstone
Grinsztejn, Beatriz
Godbole, Sheela V.
Mehendale, Sanjay
Chariyalertsak, Suwat
Santos, Breno R.
Mayer, Kenneth H.
Hoffman, Irving F.
Eshleman, Susan H.
Wang, Lei
Makhema, Joseph
Mills, Lisa A.
Sanne, Ian
Eron, Joseph
Gallant, Joel
Havlir, Diane
Swindells, Susan
Ribaudo, Heather
Burns, David
Taha, Taha E.
Celentano, David
Essex, Max
Fleming, Thomas R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2011-08-11
Volume: 365
Issue: 6
Pages: 493-505
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1105243
PMC: PMC3200068
OpenAlex: W2152505869
Cited by: 6,873
References: 35
Citations by year: 2026: 106 · 2025: 155 · 2024: 189 · 2023: 204 · 2022: 288 · 2021: 354 · 2020: 398 · 2019: 471 · 2018: 510 · 2017: 594 · 2016: 694 · 2015: 720 · 2014: 759 · 2013: 740 · 2012: 571
FWCI: 466.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
Funders: Abbott Laboratories
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Sanofi
Gilead Sciences
ViiV Healthcare
Abbott Diagnostics
Sanofi Pasteur
National Institute of Allergy and Infectious Diseases (U01AI068617, U01AI068619, U01AI068613, K24AI051982, UM1AI068619, UM1AI069418, P30AI050410, UM1AI068613, UM1AI068617, P30AI027763)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042854)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: HIV-1 prevention, early antiretroviral therapy, serodiscordant couples, sexual transmission of HIV, CD4 count, HIV-negative partners, tuberculosis, bacterial infection, AIDS mortality, HPTN 052
MeSH terms: Adolescent, Adult, Drug Therapy, Combination, Female, HIV Seropositivity, Humans, Male, Sexual Partners, HIV-1, HIV Infections, Proportional Hazards Models, Treatment Outcome, Disease Progression, Spouses, Disease Transmission, Infectious, Anti-Retroviral Agents, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of HIV-1 infection with early antiretroviral therapy.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks